Abstract
The type of regimen used might result in
mobilization of phenotypically and functionally different CD34+ cells. We compared the phenotype of CD34+ cells in
leukapheresis products of three homogeneous groups: I, healthy individuals treated with granulocyte colony-stimulating factor (G-CSF) alone (n = 13); II, patients mobilized
with G-CSF following chemotherapy (n = 16);
... read more